Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01965938 · ClinicalTrials.gov registry record · NA
RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01965938: Completed NA study, sponsored by Vanderbilt University.
NCT01965938 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01965938, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
We will conduct a randomized trial comparing the success rate and time to intubation using the RIFL vs. the fiberoptic bronchoscope, as the latter is commonly held to be the gold standard of difficult airway devices. Specifically, we wish to compare the of intubation between the two devices in patients with potentially difficult airways as defined by an oropharyngeal class 3-4, BMI greater than 35, or in patients with a history of difficult intubation using direct laryngoscopy.
Primary Outcome
Time (in seconds) from first placement of the intubating scope in the oral cavity until proper endotracheal tube placement is confirmed by the presence of End Tidal Co2 (etCO2). Time to successful intubation was defined as the period from when the tip of the RIFL or FOB passed the incisors until withdrawal past that same point after successful intubation.
Interventions
- DEVICE RIFL (Rigid and Flexing Laryngoscope)
- DEVICE Fiberoptic Bronchoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01965938 record still lists
NCT01965938 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which RIFL (Rigid and Flexing Laryngoscope) is the first listed.
NCT01965938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01965938 about?
NCT01965938 is a clinical study titled "RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope". We will conduct a randomized trial comparing the success rate and time to intubation using the RIFL vs. the fiberoptic bronchoscope, as the latter is commonly held to be the gold standard of difficult airway devices. Specifically, we wish to compare the of intubation between the two devices in patie...
What is the current status of trial NCT01965938?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-09. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01965938?
The interventions under investigation include: RIFL (Rigid and Flexing Laryngoscope) (DEVICE), Fiberoptic Bronchoscope (DEVICE).
Who is sponsoring clinical trial NCT01965938?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01965938's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia